[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2015DN02930A - - Google Patents

Info

Publication number
IN2015DN02930A
IN2015DN02930A IN2930DEN2015A IN2015DN02930A IN 2015DN02930 A IN2015DN02930 A IN 2015DN02930A IN 2930DEN2015 A IN2930DEN2015 A IN 2930DEN2015A IN 2015DN02930 A IN2015DN02930 A IN 2015DN02930A
Authority
IN
India
Prior art keywords
luliconazole
pharmaceutical formulation
specifying
establish
prepare
Prior art date
Application number
Other languages
English (en)
Inventor
Takaaki; Masuda
Hiroshi; Yamaguchi
Original Assignee
Pola Pharma Inc
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc, Nihon Nohyaku Co Ltd filed Critical Pola Pharma Inc
Publication of IN2015DN02930A publication Critical patent/IN2015DN02930A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN2930DEN2015 2012-09-14 2013-02-19 IN2015DN02930A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012202696A JP5460797B1 (ja) 2012-09-14 2012-09-14 アミド誘導体及び安定性指標としてのその使用
PCT/JP2013/055025 WO2014041825A1 (en) 2012-09-14 2013-02-19 Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulation

Publications (1)

Publication Number Publication Date
IN2015DN02930A true IN2015DN02930A (ja) 2015-09-18

Family

ID=47884458

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2930DEN2015 IN2015DN02930A (ja) 2012-09-14 2013-02-19

Country Status (7)

Country Link
US (1) US9145401B2 (ja)
EP (1) EP2895480A1 (ja)
JP (1) JP5460797B1 (ja)
CN (1) CN104662017A (ja)
IN (1) IN2015DN02930A (ja)
RU (1) RU2612557C2 (ja)
WO (1) WO2014041825A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
CN102481286B (zh) 2009-08-25 2014-02-26 宝丽制药股份有限公司 抗真菌药物组合物
CN102933201B (zh) 2010-06-11 2015-12-16 宝丽制药股份有限公司 抗真菌药物组合物
RU2603963C2 (ru) 2012-09-14 2016-12-10 Пола Фарма Инк. Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла
WO2014041846A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
IN2015DN02929A (ja) 2012-09-14 2015-09-18 Pola Pharma Inc
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5926756B2 (ja) * 2014-03-26 2016-05-25 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5623671B1 (ja) * 2014-07-23 2014-11-12 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
US10703744B2 (en) * 2014-12-12 2020-07-07 Glenmark Life Sciences Limited Process for preparation of luliconazole
US20220074832A1 (en) * 2019-02-07 2022-03-10 Shimadzu Corporation Analysis method, analysis device and non-transitory computer readable recording medium storing

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
KR100386491B1 (ko) 1995-07-08 2003-08-21 니혼노야쿠가부시키가이샤 항진균제,이를위한화합물및이의제조방법
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
JP5160409B2 (ja) 2006-03-08 2013-03-13 日本農薬株式会社 外用の医薬組成物
RU2419429C2 (ru) 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
US8058303B2 (en) 2006-03-08 2011-11-15 Nihon Nohyaku Co, Ltd Pharmaceutical composition for external use
EP2191826B1 (en) 2007-09-05 2017-03-08 Pola Pharma Inc. Pharmaceutical composition
KR20100075476A (ko) * 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 항진균 조성물
EP2191828B1 (en) 2007-09-05 2016-08-10 Pola Pharma Inc. Antifungal pharmaceutical composition
EP2745692A1 (en) * 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
CN102481286B (zh) 2009-08-25 2014-02-26 宝丽制药股份有限公司 抗真菌药物组合物
CN102933201B (zh) 2010-06-11 2015-12-16 宝丽制药股份有限公司 抗真菌药物组合物
CN104619320A (zh) 2012-09-14 2015-05-13 宝丽制药股份有限公司 含有卢立康唑的药物组合物
WO2014041846A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
IN2015DN02929A (ja) 2012-09-14 2015-09-18 Pola Pharma Inc
RU2603963C2 (ru) 2012-09-14 2016-12-10 Пола Фарма Инк. Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質

Also Published As

Publication number Publication date
EP2895480A1 (en) 2015-07-22
CN104662017A (zh) 2015-05-27
US20150191456A1 (en) 2015-07-09
RU2612557C2 (ru) 2017-03-09
RU2015113587A (ru) 2016-11-10
WO2014041825A1 (en) 2014-03-20
US9145401B2 (en) 2015-09-29
JP5460797B1 (ja) 2014-04-02
JP2014058449A (ja) 2014-04-03

Similar Documents

Publication Publication Date Title
IN2015DN02930A (ja)
PH12019500176A1 (en) Heterocyclic compounds and ther uses
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
IN2015MN00405A (ja)
CR20140464A (es) Compuestos de heterociclilo
CU20140089A7 (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CO7210068A1 (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen
CU20140095A7 (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UA114657C2 (uk) Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2
UY35467A (es) Compuestos orgánicos
SV2014004770A (es) Nuevos derivados de pirrol, su procedimiento de preparación y los composiciones farmacéuticas que los contienen
MX356342B (es) Agente de control de endoparásitos y método para usarlo.
MX2015011534A (es) Nuevos derivados de pirazol.
PH12019501178A1 (en) Thiopene derivatives as antiviral agents
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
MY174000A (en) Novel pyridine derivatives
UY33874A (es) Derivados de ácido 3-heteroaroilamino-propiónico sustituidos y su uso como sustancias farmacéuticas
CR20150555A (es) Nuevos derivados de pirrolo[2,3-d]pirimidina
MX2015012416A (es) Compuestos heterociclicos y sus usos.
UY35997A (es) Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
IN2015DN00950A (ja)
CY1119984T1 (el) Σταθεροποιημενη αμορφη μορφη αγομελατινης, μια μεθοδος για την παρασκευη της και φαρμακευτικες συνθεσεις που την περιεχουν
AU2013347232A8 (en) 3-Aminocyclopentane carboxamide derivatives
PH12018502555A1 (en) Cosmetic base including amide alcohol ester, and cosmetic
GEP20196957B (en) Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations